retatrutide trial results produces up to 30.3% weight loss in Phase 3 Experimental drug Retatrutide shows promising

Metabolic Boost : Some research suggests GLP-1 may increase energy expenditure, helping you burn more calories throughout the day

Some patients achieve meaningful weight loss at doses below the maximum 3.0mg daily

For immunofluorescence staining, the lung sections were incubated with primary antibodies against -SMA (1:50, Servicebio, Wuhan, China, GB13044) and ASC (1:50, Cell Signaling Technology, Danvers, MA, USA, 67824s) overnight at 4 C

What Patients Consistently Tell Us Common themes patients share about the program

Pierre-Louis: But when we take these GLP-1 agonists, these drugs, it kind of lingers in our system for a lot longer, sort of creating a bigger sense of satiety than we would naturally